Início › Câncer Metastático › Arizona › Tucson
Ensaios clínicos de Câncer Metastático em Tucson, AZ
14 estudos para Câncer Metastático estão buscando participantes em locais em Tucson e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RecrutandoFase 1
- University of Arizona Cancer Center, Tucson
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecrutandoFase 2/3
- The University of Arizona Cancer Center, Tucson
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RecrutandoFase 2
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecrutandoFase 3
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RecrutandoFase 3
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecrutandoFase 3
- The University of Arizona Cancer Center - North Campus, Tucson
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RecrutandoFase 3
- University of Arizona-Cancer Center, Tucson
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecrutandoFase 1
- University of Arizona - Cancer Center, Tucson
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Arizona Cancer Center at University of Arizona, Tucson
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecrutandoFase 3
- Research Site, Tucson
Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
Recrutando
- University of Arizona Cancer Center, Tucson
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RecrutandoFase 3
- The University of Arizona Cancer Center, Tucson
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RecrutandoFase 1
- The University of Arizona Cancer Center, Tucson
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RecrutandoFase 1
- University of Arizona, Tucson
Ensaios de Câncer Metastático em outras cidades
- Houston, TX104 estudos
- New York City, NY93 estudos
- Nashville, TN70 estudos
- Boston, MA63 estudos
- Los Angeles, CA57 estudos
- St. Louis, MO54 estudos
- Arlington, VA53 estudos
- Philadelphia, PA46 estudos
- Chicago, IL45 estudos
- San Antonio, TX44 estudos
- Washington, DC43 estudos
- Dallas, TX42 estudos
Outros estudos em Tucson
- Câncer de Mama20 estudos
- Obesidade18 estudos
- Câncer de Pulmão de Não Pequenas Células17 estudos
- Sobrepeso15 estudos
- Câncer (todos os tipos)12 estudos
- Doença Cardiovascular12 estudos
- Câncer Colorretal11 estudos
- Câncer de Próstata11 estudos
- Diabetes tipo 211 estudos
- Doença Hepática Esteatótica10 estudos
- Insuficiência Cardíaca10 estudos
- Pressão Alta10 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.